Antibodies

Jump to Filters

View as table Download

Cd8a Rat Monoclonal Antibody [Clone ID: YTS 169.4]

TA385766

USD 523.00

2 Weeks

Recombinant Anti-CD8 alpha/Lyt-2 (Clone YTS 169.4)

Applications	FC, IHC
Reactivities	Mouse
Conjugation	Unconjugated
Modifications	This is a chimeric antibody created to reduce immunogenicity during in vivo applications.

Active filters

Applications

Edit Clear

Modifications

This is a chimeric antibody created to reduce immunogenicity during in vivo applications.

Edit Clear

Filter by

Antibodies

Primary Antibodies

CD8A

Mouse

IHC

Rat

IgG2b, kappa

Monoclonal

Unconjugated

Unmodified

Phospho-specific

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2a format, for improved compatibility with existing reagents, assays and techniques.

Acetyl K12

Acetyl K5

Phospho S127

Phospho S39

Phospho S727

Phospho S795

This chimeric rabbit antibody was made using the variable domain sequences of the original format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This constant region of this antibody has been modified to bind to Protein A, allowing highly-specific purification of this antibody by Protein A-affinity column.

This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques.

TriMethyl K56

Acetyl K15

Acetyl K18

Acetyl K23

Acetyl K27

Acetyl K56

Acetyl K8

Acetyl K9

Acetyl K9/K14/K18/K23/K27

Asymmetric DiMethyl R3

DiMethyl K385

MonoMethyl K36

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.

Pan DiMethyl-lysine

Phospho S1

Phospho S10

Phospho S10/T11

Phospho S104

Phospho S1177

Phospho S1248

Phospho S15

Phospho S157

Phospho S182

Phospho S240/244

Phospho S243

Phospho S280

Phospho S33

Phospho S33/S37/T41

Phospho S37

Phospho S376

Phospho S425

Phospho S428

Phospho S455

Phospho S465/467 + S423/425

Phospho S473

Phospho S473,Phospho S474,Phospho S472

Phospho S5

Phospho S51

Phospho S529

Phospho S612

Phospho S62

Phospho S73

Phospho S80

Phospho S82

Phospho S89

Phospho S957

Phospho Ser416

Phospho T11

Phospho T17

Phospho T179

Phospho T18/S19

Phospho T183/T172

Phospho T1989

Phospho T202/Y204 + T185/Y187

Phospho T24,Phospho T32,Phospho T28

Phospho T286

Phospho T308

Phospho T32

Phospho T320

Phospho T37/46

Phospho T389

Phospho T45

Phospho T58

Phospho T6

Phospho T69/71

Phospho T69/T71

Phospho T70

Phospho T91

Phospho Y1007/1008

Phospho Y1217

Phospho Y1349

Phospho Y15

Phospho Y182

Phospho Y207

Phospho Y245

Phospho Y412

Phospho Y694

Phospho Y705

This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG1 format, for improved compatibility with existing reagents, assays and techniques.

This chimeric rabbit antibody was made using the variable domain sequences of the original rat IgG2b format, for improved compatibility with existing reagents, assays and techniques.

This is a chimeric antibody created to reduce immunogenicity during in vivo applications.

This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques.

This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques.

phospho T1079,Phospho T1041

HT BioMarker Screening/Drug Discovery

CAR T-cell

Neuroscience

Antibodies

Active filters

Applications

Modifications

Filter by

Category

Target Symbol

Reactivities

Antibody Hosts

Isotypes

Clonalities

Conjugates

Viral Gene Delivery

ELISA Center

Other Tools

Hot Topics

HT BioMarker Screening/Drug Discovery

CAR T-cell

Oncology

Virus

Signal Transduction

Technology

Who we are

Company News

Careers

Antibodies

Active filters

Applications

Modifications

Filter by

Category

Target Symbol

Reactivities

Antibody Hosts

Isotypes

Clonalities

Conjugates

Category

SubCategory

Target Symbol

Species

Reactivities

Applications

Antibody Hosts

Isotypes

Clonalities

Conjugates

Carrier-free

Knockout (KO) Validation

Recombinant

Expression Hosts

Biosimilar

Lentivirus

Tags

Vectors

Reporters

Modifications

Protein Source

Mutants

Assay Types

Assay Platforms

Disease States

Diagnosis

Tissues

TissueScan Types

QC Levels

C-Tag

Mammalian Cell Selection

Families

Pathways

Brands

Citations

Availabilities

__Category ID

__Matched ELISA Pair

__PT